brazilin has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Jia, L; Liu, F; Lu, F; Sang, J; Wang, Y; Wei, W; Zhao, F; Zhao, W | 1 |
| Batchelor, M; Benilova, I; Bieschke, J; Caughey, B; Collinge, J; Jat, PS; Kedia, N; Nahass, GR; Radford, SE; Reilly, M; Sessions, RB; Sobott, F; Spehar, K; Sun, Y; Xu, Y | 1 |
2 other study(ies) available for brazilin and alpha-synuclein
| Article | Year |
|---|---|
Brazilin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Protects against Amyloid-Induced Cytotoxicity.
Topics: alpha-Synuclein; Amino Acid Motifs; Amyloid; Animals; Benzopyrans; Cell Line; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; PC12 Cells; Protective Agents; Protein Aggregates; Protein Binding; Rats | 2019 |
Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Peptides; Animals; Benzopyrans; Brain; Humans; Mice; Molecular Conformation; Molecular Docking Simulation; Neurons; Parkinson Disease | 2021 |